Investing in AtriCure, Inc. (ATRC)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)26.199
Intrinsic value (DCF)38.1458
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

AtriCure Inc. (ATRC) is a medical technology company that focuses on developing innovative solutions for the treatment of atrial fibrillation and related conditions. Founded in 2000, the company has become a leading provider of surgical ablation and minimally invasive products designed to improve the outcomes of cardiac surgeries. AtriCure's flagship product line, the Isolator Synergy System, is a groundbreaking technology that combines the use of radiofrequency energy and cryoenergy to deliver precisely controlled ablations. This allows for more efficient and effective treatment of atrial fibrillation, resulting in reduced complication rates and faster recovery times for patients. In addition to its pioneering products, AtriCure also offers educational programs and support services for surgeons and healthcare professionals to ensure proper use and integration of its technologies. With a commitment to advancing the field of cardiac care, AtriCure continues to expand its product portfolio and invest in research and development to improve the lives of those affected by heart conditions.